Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC: Afrezza With Basal Combination
NCT05243628Phase 4Completed
- Sponsor
- MannKind
- Start
- Mar 2022
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of TI-Inhalation Powder B in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Mar 2022; status: completed.
02
Drugs
TI-Inhalation Powder B
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT05243628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243628.